Document Detail

The health economics of the treatment of hyperlipidemia and hypertension.
MedLine Citation:
PMID:  10555609     Owner:  NLM     Status:  MEDLINE    
In the current economic climate it is important to demonstrate that healthcare resources are being used efficiently. As a consequence, pharmacoeconomic analyses are invaluable for assessing the cost-effectiveness of new therapeutic strategies. A condition with recurrent morbid events that are costly to treat provides the greatest potential for cost savings. In contrast, there is less opportunity to redeem original treatment costs when a condition is associated with infrequent and inexpensive morbidity. Consequently, treatment strategies that have a rapid onset and substantial impact on disease progression are likely to be the most highly cost-effective forms of therapy. Elevated blood pressure in the elderly and established coronary heart disease (CHD) are both associated with high rates of costly cardiovascular events (eg, stroke, myocardial infarction, and heart failure). Clinical trials have shown that administration of blood-pressure-lowering agents to elderly hypertensives and the treatment of hypercholesterolemia with statins in the secondary prevention of CHD are highly effective strategies for reducing this morbidity. Pharmacoeconomic analyses of the data from these clinical trials now provide an additional assessment of their cost-effectiveness. The results of these analyses suggest that blood-pressure-lowering therapy for the elderly and the use of statins to control hypercholesterolemia in patients at high risk of CHD are extremely cost-effective, compared with many other routine medical interventions.
J McMurray
Related Documents :
11763689 - The prevalence and treatment of hypertension in the elderly population of the mexican i...
24725259 - In vivo assessment by mach-zehnder double-beam interferometry of the invasive force ex...
2009699 - Does tortuosity in cerebral arterioles impair down-autoregulation in hypertensives and ...
3361659 - New generator for low pressure lithotripsy with the dornier hm3: preliminary experience...
2215839 - Postprandial blood pressure reduction.
1327629 - Disparities in circulatory adjustment to standing between young and elderly subjects ex...
24993169 - Precise tumor size measurement under constant pressure by novel real-time micro-electro...
15613219 - Hyperthyroidism mimicking increased intracranial pressure.
21388299 - Biomechanical analysis of the effect of intracranial pressure on the orbital distances ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American journal of hypertension     Volume:  12     ISSN:  0895-7061     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  1999 Oct 
Date Detail:
Created Date:  1999-12-06     Completed Date:  1999-12-06     Revised Date:  2009-02-24    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  99S-104S     Citation Subset:  IM    
Department of Cardiology, Western Infirmary, Glasgow, Scotland, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / economics*,  therapeutic use
Antilipemic Agents / economics*,  therapeutic use
Coronary Disease / economics,  prevention & control
Costs and Cost Analysis
Economics, Pharmaceutical*
Hyperlipidemias / drug therapy,  economics*
Hypertension / drug therapy,  economics*
Reg. No./Substance:
0/Antihypertensive Agents; 0/Antilipemic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Blood pressure, cholesterol, and common causes of death: a review. Prospective Studies Collaboration...
Next Document:  The essence of effective treatment and compliance is simplicity.